Movers Archives - Page 2348 of 2348

1 minute read

This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft

July 1, 10:45 AM

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) creates new possibilities via medicine to cure diseases and improve people's lives, and over the past year, marked gains in investors’ portfolios.

AAPL

1 minute read

Cryptocurrency Decentraland’s Price Increased More Than 6% Within 24 hours

By Benzinga Insights

July 1, 10:15 AM

Decentraland's (CRYPTO: MANA) price has increased 6.66% over the past 24 hours to $0.86, which is in the opposite direction of its trend over the past week, where it has experienced a 7.0% loss, moving from $0.92 to its current price.

$MANA

1 minute read

Here’s Why VerifyMe Shares Are Trading Higher Today

By Anusuya Lahiri

July 1, 9:42 AM

VerifyMe, Inc (NASDAQ:VRME) elected not to extend the period for a special purpose acquisition company (SPAC) merger with G3 VRM Acquisition Corp (NASDAQ:GGGVU). …

GGGVU

1 minute read

Why Nio Stock Is Rising Today

By Adam Eckert

July 1, 9:07 AM

NIO Inc (NYSE: NIO) shares are trading higher Friday after the company provided a delivery update for June, as well as the second quarter.

NIO

1 minute read

Endo Posts Disappointing Data From Frozen Shoulder Trial

By Vandana Singh

July 1, 8:15 AM

Endo International plc (NASDAQ:ENDP) has announced topline results from its Phase 2 study of collagenase clostridium histolyticum (CCH) in participants with…

ENDP

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

July 1, 8:11 AM

ADXN

1 minute read

NIO Shares Gain As June Deliveries Jump By Over 60% Reflecting Recovery

By Anusuya Lahiri

July 1, 6:55 AM

NIO Inc (NYSE: NIO) reported its June and sec

NIO

5 minute read

Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday

By Lisa Levin

July 1, 4:52 AM

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.

ADSE